# Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention

> **NCT06148441** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- In-stent Restenosis

## Interventions

- **DIAGNOSTIC_TEST:** bone morphogenetic protein-2 (BMP-2)

## Key facts

- **NCT ID:** NCT06148441
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06148441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06148441, "Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06148441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*